Ernest Nadal

53PUBLICATIONS
366CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer diagnosisSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 27, 2026
Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial.

|Oct 02, 2026
SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.

|Jun 22, 2026
Targeting KRAS Codon 13 Mutations Using Direct Combination Approaches in Non-Small Cell Lung Cancer.

|Jun 22, 2026
EML4-ALK Mediates Resistance to KRASG12C Inhibition and Induces an Oncogenic Dependency by Rewiring Signaling through the Wild-Type RAS Pathway.

|May 20, 2026
Metabolic vulnerabilities in pleural mesothelioma.

|Apr 10, 2026
Pseudo-senescence induced by palbociclib does not sensitise pleural mesothelioma cells to combinations with senolytics.

Iswarya Sreeram, Sílvia Plans-Marin, Mabel Cruz-Rodríguez

Pageof 9

Frequent Collaborators

8 joint publications

Mariano Provencio Pulla

8 joint publications

Alberto Cruz-Bermúdez

8 joint publications

Javier de Castro-Carpeño

7 joint publications

Alex Martínez-Martí